Award
Delivery Order #SPE2DR26F7DZ7
Delivery Order for Ondansetron Tablets Under AmerisourceBergen IDV Contract
Buyer
Defense Logistics Agency
Award Amount
$3,695.27
Ceiling
$3,695.27
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26F7DZ7
NAICS
424210
This award is a delivery order contract assigned to AmerisourceBergen Drug Corp, a prominent pharmaceutical distributor, under an existing indefinite delivery vehicle (IDV) contract focused on pharmaceutical services. The contract involves procuring Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting, reflecting the agency's continued commitment to securing essential pharmaceutical supplies. The contract's scope includes timely delivery of these tablets, supporting healthcare operations efficiently within a brief, defined timeframe. This delivery order was competitively issued under the established IDV, emphasizing streamlined procurement processes for critical medical products. The performance period is short-term, covering a two-day window, ensuring prompt fulfillment of the agency's needs. This award complements previous significant contracts with AmerisourceBergen that span long-term pharmaceutical provision, demonstrating ongoing collaboration in healthcare support services.
Description
4571088197!ONDANSETRON HCL 4 MG TABLET 30S